Published in

Springer Nature [academic journals on nature.com], Molecular Psychiatry, 10(26), p. 6054-6064, 2021

DOI: 10.1038/s41380-021-01266-z

Links

Tools

Export citation

Search in Google Scholar

Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE ε2 protective effect in Alzheimer disease

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractMechanisms underlying the protective effect of apolipoprotein E (APOE) ε2 against Alzheimer disease (AD) are not well understood. We analyzed gene expression data derived from autopsied brains donated by 982 individuals including 135APOEɛ2/ɛ3 carriers. Complement pathway genesC4AandC4Bwere among the most significantly differentially expressed genes between ɛ2/ɛ3 AD cases and controls. We also identified anAPOEε2/ε3 AD-specific co-expression network enriched for astrocytes, oligodendrocytes and oligodendrocyte progenitor cells containing the genesC4A, C4B, andHSPA2. These genes were significantly associated with the ratio of phosphorylated tau at position 231 to total Tau but not with amyloid-β 42 level, suggesting thisAPOEɛ2 related co-expression network may primarily be involved with tau pathology.HSPA2expression was oligodendrocyte-specific and significantly associated with C4B protein. Our findings provide the first evidence of a crucial role of the complement pathway in the protective effect ofAPOEε2 for AD.